Cancer de la prostate à haut risque

Frank M. Chybowski, Jeffrey J. Larson Keller, Erik J. Bergstralh, Joseph E. Oesterling, Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters The Journal of Urology. ,vol. 145, pp. 313- 318 ,(1991) , 10.1016/S0022-5347(17)38325-8

G D Chisholm, R F Deane, G B McKelvie, C D Rennie, E L Gilliland, C P Chilton, M G Royle, N H Townell, J Breakey, S M Cresswell, J Glaholm, G M Sole, J J Bolger, M J Stower, M H Ashken, D A Tolley, F J Bramble, P A Jones, R A Styles, Moffat Lef., R W Glashan, Rhind, A Radley, G J Fellows, J Crowther, B Hafner, S Knight, E Thompson, J Smith, J Burrett, P B Clark, J Boreham, R Peto, L N Jurczyk, B A DeSousa, S Parish, Logie Jrc., Ross Rta., Cox, K Perry, T P Stephenson, K K Sethia, Turner Dtl., M Davies, Harrison Gsm., G F Carswell, Rogers Acn., M Lucas, M R Heal, V Boag, J Hetherington, D Kirk, Charlton Cac., Shepheard Bgf., N A Green, M F Smith, T B Hargreave, Moore Kth., R J Morgan, K N Bullock, Bevis Cra., J B Anderson, A L Stewart, Newling Dwk., B Richards, Grayson Cea., Gaches Cgc., P T Doyle, Robinson Mrg., S Sagar, R J Shearer, C M Evans, R A Jones, Wightman Jak., E R Coulton, J C Smith, M E French, C S Powell, Fernie Cgm., Orr Pgg., M Claridge, Gallegos Crr., G H Urwin, G M Watson, C Roberts, S Griffin, M B Rose, M Fordham, G S Watson, W T Lawrence, R Pollard, P H Smith, M J James, Grant Jbp., J P Ward, R R Hall, M Hehir, J L Williams, R W Thomson, L L Beynon, R J Luck, R Rampling, R S Adib, P English, A McGregor, C D Baumber, J W Blaxland, M H Devereux, R Clack, Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial BJUI. ,vol. 79, pp. 235- 246 ,(1997)

Xavier Rebillard, François Grima, Alain Ruffion, Temps de doublement du PSA et son calcul Progres En Urologie. ,vol. 15, pp. 1035- 1041 ,(2005)

Richard Valicenti, Jiandong Lu, Miljenko Pilepich, Sucha Asbell, David Grignon, Survival Advantage From Higher-Dose Radiation Therapy for Clinically Localized Prostate Cancer Treated on the Radiation Therapy Oncology Group Trials Journal of Clinical Oncology. ,vol. 18, pp. 2740- 2746 ,(2000) , 10.1200/JCO.2000.18.14.2740

Gunar K. Zagars, Alan Pollack, Andrew C. von Eschenbach, Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era. Cancer. ,vol. 79, pp. 1370- 1380 ,(1997) , 10.1002/(SICI)1097-0142(19970401)79:7<1370::AID-CNCR15>3.0.CO;2-X

G. Aus, J. Hugosson, L. Norlen, Long-term Survival and Mortality in Prostate Cancer Treated with Noncurative Intent The Journal of Urology. ,vol. 154, pp. 460- 465 ,(1995) , 10.1016/S0022-5347(01)67074-5

Fernando P. Secin, Fernando J. Bianco, Andrew J. Vickers, Victor Reuter, Thomas Wheeler, Paul A. Fearn, James A. Eastham, Peter T. Scardino, Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy Cancer. ,vol. 106, pp. 2369- 2375 ,(2006) , 10.1002/CNCR.21895

Lars Egevad, William C. Allsbrook, Jonathan I. Epstein, Current practice of Gleason grading among genitourinary pathologists Human Pathology. ,vol. 36, pp. 5- 9 ,(2005) , 10.1016/J.HUMPATH.2004.10.001

Jun Kawakami, Janet E. Cowan, Eric P. Elkin, David M. Latini, Janeen DuChane, Peter R. Carroll, , Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Cancer. ,vol. 106, pp. 1708- 1714 ,(2006) , 10.1002/CNCR.21799

F. Algaba, Y. Arce, A. Oliver, C. Barandica, J.M Santaularia, R. Montañés, Prognostic Parameters Other Than Gleason Score for the Daily Evaluation of Prostate Cancer in Needle Biopsy European Urology. ,vol. 48, pp. 566- 571 ,(2005) , 10.1016/J.EURURO.2005.06.016